Prestige Consumer Healthcare Inc. (PBH) |
| 47.53 -0.94 (-1.94%) 05-29 16:00 |
| Open: | 48.475 |
| High: | 48.82 |
| Low: | 47.22 |
| Volume: | 540,131 |
| Market Cap: | 2,252(M) |
| PE Ratio: | 12.16 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Distribution |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 60.29 |
| Resistance 1: | 53.54 |
| Pivot price: | 48.46 |
| Support 1: | 42.62 |
| Support 2: | 35.46 |
| 52w High: | 87.12 |
| 52w Low: | 42.62 |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
| EPS | 3.910 |
| Book Value | 38.660 |
| PEG Ratio | 1.49 |
| Gross Profit | 12.791 |
| Profit Margin (%) | 17.48 |
| Operating Margin (%) | 26.81 |
| Return on Assets (ttm) | 5.6 |
| Return on Equity (ttm) | 10.2 |
Fri, 29 May 2026
Prestige Consumer Healthcare Inc. (PBH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Thu, 28 May 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH - PR Newswire
Mon, 25 May 2026
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 39% Upside Potential Amidst Strong Analyst Ratings - DirectorsTalk Interviews
Sun, 24 May 2026
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Fri, 22 May 2026
Prestige Consumer Healthcare, Inc. (PBH) Securities Fraud Investigation - Levi & Korsinsky - Morningstar
Tue, 19 May 2026
INVESTOR ALERT: Investigation of Prestige Consumer Healthcare Inc. (PBH) announced by Holzer & Holzer, LLC - GlobeNewswire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |